OBJECTIVE: To estimate the prevalence of diagnosed diabetes among American Indians and Alaska Natives served by the IHS. RESEARCH DESIGN AND METHODS: This was a cross-sectional study of the 1987 IHS national outpatient data base. RESULTS: Prevalence rates of diagnosed diabetes determined from the IHS outpatient data base were consistent with recent studies of diabetes in different IHS areas. IHS-wide, age-adjusted prevalence was 69/100,000, or 2.8 times the U.S. rate. There was considerable variation in prevalence rates of diabetes throughout the country, with rates ranging from 15.3/100,000 in Alaska to 119.2/100,000 in southern Arizona. CONCLUSIONS: This study documented the high prevalence of diabetes among American Indians and Alaska Natives and the wide variation in rates between different tribal groups. This study also demonstrated the feasibility of using an outpatient data base to estimate rates of disease that have uniform methods of diagnosis and result in frequent clinic visits.
OBJECTIVE: To estimate the prevalence of diagnosed diabetes among American Indians and Alaska Natives served by the IHS. RESEARCH DESIGN AND METHODS: This was a cross-sectional study of the 1987 IHS national outpatient data base. RESULTS: Prevalence rates of diagnosed diabetes determined from the IHS outpatient data base were consistent with recent studies of diabetes in different IHS areas. IHS-wide, age-adjusted prevalence was 69/100,000, or 2.8 times the U.S. rate. There was considerable variation in prevalence rates of diabetes throughout the country, with rates ranging from 15.3/100,000 in Alaska to 119.2/100,000 in southern Arizona. CONCLUSIONS: This study documented the high prevalence of diabetes among American Indians and Alaska Natives and the wide variation in rates between different tribal groups. This study also demonstrated the feasibility of using an outpatient data base to estimate rates of disease that have uniform methods of diagnosis and result in frequent clinic visits.
Authors: D E Peterson; P L Remington; M A Kuykendall; M S Kanarek; J M Diedrich; H A Anderson Journal: Public Health Rep Date: 1994 Nov-Dec Impact factor: 2.792
Authors: Maria Rosario G Araneta; Deborah J Morton; Lina Lantion-Ang; Andrew Grandinetti; Mary Anne Lim-Abrahan; Healani Chang; Elizabeth Barrett-Connor; Beatrice L Rodriguez; Deborah L Wingard Journal: Diabetes Res Clin Pract Date: 2005-10-19 Impact factor: 5.602
Authors: Kelly J Acton; Nilka Ríos Burrows; Kelly Moore; Linda Querec; Linda S Geiss; Michael M Engelgau Journal: Am J Public Health Date: 2002-09 Impact factor: 9.308
Authors: Luohua Jiang; Janette Beals; Nancy R Whitesell; Yvette Roubideaux; Spero M Manson Journal: Qual Life Res Date: 2009-06-14 Impact factor: 4.147
Authors: Ann Bullock; Karen Sheff; Israel Hora; Nilka Rios Burrows; Stephen R Benoit; Sharon H Saydah; Carmen Licavoli Hardin; Edward W Gregg Journal: BMJ Open Diabetes Res Care Date: 2020-04
Authors: Lyle G Best; Esther García-Esquinas; Jeun-Liang Yeh; Fawn Yeh; Ying Zhang; Elisa T Lee; Barbara V Howard; John H Farley; Thomas K Welty; Dorothy A Rhoades; Everett R Rhoades; Jason G Umans; Ana Navas-Acien Journal: Cancer Causes Control Date: 2015-08-07 Impact factor: 2.506